Brief: Neovacs completes patient enrollment in phase IIb clinical study of IFNalpha kinoid

Neovacs SA

20/06/2017 06:00

June 20 (Reuters) - NEOVACS SA  ALNEV.PA : 
    * NEOVACS ANNOUNCES THE COMPLETION OF PATIENT ENROLLMENT IN 
PHASE IIB CLINICAL STUDY OF IFNALPHA KINOID IN LUPUS 
    * LOOKING FORWARD TO RESULTS FROM STUDY IN Q2-2018 
 
Source text for Eikon:  ID:nGNE6ZgdBn  
Further company coverage:  ALNEV.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))